Sign up for our recent event



Prostate cancer breakthrough as UK team develops more accurate test

Ultrasound technique overcomes problems with current methods to diagnose the most common cancer in men Scientists have announced the development of a highly accurate and reliable technique for diagnosing prostate cancer. The Dundee University-based team say they have used an ultrasound process called shear wave elastography (SWE) to detect prostate tumours. The method is non-invasive and cheaper than current detection techniques. Prostate cancer has become the most common cancer in men in the UK. One in eight men will develop the condition...


Breast screening: What went wrong?

How does breast cancer screening work in England? Breast screening aims to find cancer early by using an X-ray called a mammogram that can spot tumours when they’re too small to see or feel. Around one-in-eight women in the UK are diagnosed with breast cancer during their lifetime, and if it’s detected early treatment is more likely to be successful. As the likelihood of getting breast cancer increases with age, women in the UK from the age of 50 who are registered with...


Theresa May launches £75m drive against prostate cancer

Project will see 40,000 men recruited for research into the disease, which kills more than 11,000 a year. The prime minister is to launch a new drive against prostate cancer, which kills more than 11,000 men every year in the UK and causes great anxiety and sometimes suffering for the 47,000 men who get a diagnosis. Theresa May will announce £75m for research that will recruit 40,000 men into trials for better diagnosis and treatments for the disease, which recently overtook breast...


Prostate cancer treatment ‘could help more patients’

One of the largest clinical trials for prostate cancer has given “powerful results”, say UK researchers. A drug for treating prostate cancer that has spread was found to save lives when offered earlier, a study found. The trial looked at abiraterone as an additional treatment in patients with prostate cancer who were about to start long-term hormone therapy. Abiraterone improved survival, according to results published in the New England Journal of Medicine. Prof Nicholas James, from the University of Birmingham, who led the...